World Hepatitis Day urges action to accelerate hepatitis testing and treatment globally.

WHO emphasizes the theme "One life, one liver" for this year's World Hepatitis Day.

[{"selector":"#anim-3e1c4fde-c03d-4181-8235-7cebeda5bda8","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}]

Globally, 354 million people live with chronic hepatitis B and C, leading to 1.1 million annual deaths.

[{"selector":"#anim-0b218786-764f-40a3-a34d-9d01173d37d2","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}]

Hepatitis is often referred to as the "silent killer" due to many people remaining unaware of their infection.

[{"selector":"#anim-dcace054-951d-4889-a84a-a0585471e56c","keyframes":[{"offset":0,"transform":"translate3d(0, -297.4748%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.29,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.45,"transform":"translate3d(0, -83.64991376%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.61,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.71,"transform":"translate3d(0, -28.438590880000003%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.8,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.85,"transform":"translate3d(0, -10.679345320000001%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.92,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.96,"transform":"translate3d(0, -4.64060688%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":1,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"}],"delay":0,"duration":600,"fill":"both"}]

Safe vaccines for hepatitis B and effective antiviral drugs for hepatitis B and C are available.

[{"selector":"#anim-899b9d2b-5c03-4892-8068-fa935296d02a","keyframes":{"transform":["translate3d(114.20119%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-96d4f8c0-dd40-4a0c-9d75-82f289327002","keyframes":{"transform":["rotateZ(180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}]

The South-East Asia Region bears around 20% of the global hepatitis mortality burden.

[{"selector":"#anim-9cf8cabe-7573-47b1-992a-8caa0674b158","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}]

81% of hepatitis-related deaths in the Region are due to hepatitis B and C infections.

[{"selector":"#anim-457acf0e-cfe1-41c9-aec3-795c483b913d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-feebddf4-cfa9-484b-8895-535551bff642","keyframes":{"transform":["translate3d(0px, 833.60744%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

The Region reports nearly half a million new hepatitis B and C infections yearly.

[{"selector":"#anim-3762c3e4-fbc1-41c8-8335-c1cb75d370ae","keyframes":{"transform":["translate3d(105.41236%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-918cf92d-236f-4b2e-a0f8-ec5469d2e655","keyframes":{"transform":["rotateZ(180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}]

Challenges remain in timely access to testing and treatment, requiring action from policy makers, healthcare providers, and the private sector.

[{"selector":"#anim-d48ccf8f-5db7-4815-9b1b-fc1875e0dd79","keyframes":{"transform":["rotate(-540deg) scale(0.1)","none"],"opacity":[0,1]},"delay":0,"duration":1000,"fill":"both","iterations":1}]